A Multicenter, Open-Label, Prospective Study with an Extension Phase to Evaluate the Efficacy and Safety of Perampanel Monotherapy in Untreated Subjects with Focal Onset Seizures with or without Focal to Bilateral Tonic-Clonic Seizures
E2007-M082-606
Study Overview
E2007
perampanel
NCT05533814, EudraCT: 2025-000521-14
Oct 2022 - Jan 2025
Epilepsy
Percentage of Participants Who Will Achieve Seizure Freedom During the 24-weeks Maintenance Period
The clinical study report (CSR) synopses, plain language results summaries (PLS) and plain language protocol synopses (PLPS) contained on this website are from clinical trials sponsored by Eisai and are provided for informational purposes only. These summaries and synopses contain data from and about the specific study population but do not include patient-level data from each study participant. The results reported in any single trial may not reflect the overall potential risks or benefits associated with Eisai’s products.
Only health care professionals may determine if a specific product is appropriate as a treatment option for a particular patient. Health care professionals should refer to the specific labelling information approved in their country when making prescribing decisions.
The information provided is not intended to commercialize or promote Eisai’s products for any unapproved uses.
All reasonable precautions have been taken to ensure the accuracy, security and confidentiality of information contained on this website. Eisai reserves the right to amend any information on this website at any time at its sole discretion.
If you have questions about any clinical trial results or protocols available on this website, please speak with the doctor, research nurse, or other team member at your trial site.
By clicking “Accept” you are acknowledging that you have read and understood this statement.
The clinical study report (CSR) synopses, plain language results summaries (PLS) and plain language protocol synopses (PLPS) contained on this website are from clinical trials sponsored by Eisai and are provided for informational purposes only. These summaries and synopses contain data from and about the specific study population but do not include patient-level data from each study participant. The results reported in any single trial may not reflect the overall potential risks or benefits associated with Eisai’s products.
Only health care professionals may determine if a specific product is appropriate as a treatment option for a particular patient. Health care professionals should refer to the specific labelling information approved in their country when making prescribing decisions.
The information provided is not intended to commercialize or promote Eisai’s products for any unapproved uses.
All reasonable precautions have been taken to ensure the accuracy, security and confidentiality of information contained on this website. Eisai reserves the right to amend any information on this website at any time at its sole discretion.
If you have questions about any clinical trial results or protocols available on this website, please speak with the doctor, research nurse, or other team member at your trial site.
By clicking “Accept” you are acknowledging that you have read and understood this statement.
ClinicalStudyDataRequest.com (CSDR) is a multi sponsor site through which qualified researchers who wish to access clinical trial data and associated information in order to conduct further research can submit their research proposal or enquiry.
CSDR Sharing is not available for this study.
CSDR
Availability
Clinical Trial Data
Redacted documents may be available upon request for this study.